5 things to know this morning

(WVLT)- Here are the top five stories from Local 8 News Anchor Casey Wheeless to get you out the door this morning. Stay connected to Local 8 News online.

1. Sessions raises prospect of special counsel on GOP concerns

Attorney General Jeff Sessions is leaving open the possibility that a special counsel could be appointed to look into Clinton Foundation dealings and a uranium deal during the Obama administration.

In a letter to the House Judiciary Committee, a Justice Department official says Sessions has directed senior federal prosecutors to evaluate concerns raised by Republican lawmakers.

The letter says the prosecutors will recommend whether an investigation is merited, whether any matters currently under investigation require more resources and whether it is necessary to appoint a special counsel.

The letter from Assistant Attorney General Stephen Boyd comes one day before Sessions is to appear before the House Judiciary Committee for a Justice Department oversight hearing.

Find a list of deals here.

2. 800 Oak Ridge workers reject medical center contract

Members of the Service Employees International Union (SEIU) Local 205 voted Monday to rejecy Methodist Medical Center of Oak Ridge's contract proposal that would cover 800 employees.

The union said the medical center's proposal would cut wages for new workers, risking staffing levels and quality care.

Find the full story here.

3.Brady Hoke addresses media as Vols interim head coach

Tennessee's weekly news conference on Monday had a new face standing behind the podium. Interim head coach Brady Hoke addressed the media for the first time with his new title.

Hoke made it clear from his opening statement the last two games are about the players, specifically the seniors. He said multiple times he knows he needs to "coach his heart out" for the team.

Find the full story here.

4. Gov't approves first-ever med with digital tracking system

The Food and Drug Administration has approved the first drug in the United States with a digital ingestion tracking system in an unprecedented step to ensure that patients with mental disorders take the medicine prescribed for them.

The drug Abilify MyCite was developed by Otsuka Pharmaceutical Co., Ltd. Abilify was first approved by the FDA in 2002 to treat schizophrenia, and the ingestible sensor, made by Proteus Digital health, was initially approved for marketing in 2012. The agency says the digitally enhanced medication "works by sending a message from the pill's sensor to a wearable patch."

Dr. Mitchell Mathis of the FDA says officials support "use of new technology in prescription drugs and is committed to working with companies to understand how the new technology might benefit patients and prescribers."

Find the full story here.

5. President Trump's son releases messages Twitter messages

Vice President Mike Pence's spokeswoman says he was unaware of Donald Trump Jr.'s contacts with WikiLeaks when he issued a denial that the Trump campaign was in cahoots with the hacking group.

Pence's press secretary, Alyssa Farah, says Pence "was never aware of anyone associated with the campaign being in contact with WikiLeaks. He first learned of this news from a published report earlier tonight."

President Donald Trump's son released screenshots Monday of his conversations with the group, in which he appears to inquire about the group's promised "leaks" from inside the Hillary Clinton campaign. The U.S. intelligence community has alleged Russian intelligence was behind the 2016 hacks.

Pence was asked about the campaign's coordination with WikiLeaks in October 2016. He said, "Nothing could be further from the truth."